Plain-English translation of NCT07334275 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This research study is testing whether a new blood test can detect tiny amounts of cancer cells remaining after prostate surgery in men with aggressive prostate cancer. By finding these cells early through a blood test, doctors hope to predict which patients are most likely to have their cancer return and may need additional treatment sooner.
After prostate surgery, doctors currently cannot reliably predict which patients will have their cancer come back. This study hopes to fill that gap by using this blood test to identify patients at highest risk of recurrence, so they can receive earlier treatment before the cancer progresses.
You likely qualify if…
You likely don't qualify if…
If you join, you would undergo your planned prostate surgery as usual. During and after your surgery, the research team would collect blood samples from you and store tissue samples from your prostate. You would then be monitored over time with additional blood tests to see if cancer cells can be detected, helping doctors track whether your cancer returns.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
Netherlands
Collaborators
Catharina Ziekenhuis Eindhoven, Canisius-Wilhelmina Hospital
Enrollment target
~50 participants
Started
September 2025
Primary completion
July 2027
Age range
18 Years and older
Sex
Male only
Last updated on clinicaltrials.gov in January 2026.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.